Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2026-05-28 @ 2:02 PM
Study NCT ID:
NCT04394351
Status:
COMPLETED
Last Update Posted:
2025-10-27
First Post:
2020-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)
Sponsor:
Regeneron Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Eosinophilic Esophagitis (EoE) | View |
Keywords: